External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

ISPOR EU 2024

November 17 - November 20

Barcelona, Spain

ispor.org

Add to calendar

Medical Materials

Agenda

Coming soon

08:00 AM

Duration 3hrs Barcelona, Spain

Cost Consequence Analysis of Using the Elecsys Anti-Müllerian Hormone Plus Immunoassay as Part of Polycystic Ovary Syndrome Assessment in the United Kingdom

Osvaldo Ulises Garay, Anna-Maria Olziersky, Joop Laven, Rebecca Mawson, Terhi Piltonen, Stephen Franks, Johanna Sillman

Gynaecology

Add to calendar

09:30 AM

Duration 3hrs Barcelona, Spain

Timing of Next-Generation Sequencing (NGS) Relative to First-Line Therapy in Lung Cancer: Insights from the Global WAYFIND-R Registry

Rodrigo Dienstmann

Oncology - HealthTech

Add to calendar

Duration 3hrs Barcelona, Spain

Cost-Effectiveness Analysis (CEA) of Pertuzumab and Trastuzumab (PH) + Chemotherapy (CT) Versus H + CT in HER2-Positive Early Breast Cancer (EBC): Updated Model Using Data from the 8.4-Year Follow-Up of APHINITY

Svenn A. Kommandantvold, Matthieu J. Schlögel, Lucia Ruiz de Alda, Siobhán Browne

Oncology | Breast Cancer

Add to calendar

08:00 AM

Duration 150mins Barcelona, Spain

Utility Analysis of Crovalimab and Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Christian Bührer

Haematology | Paroxysmal Nocturnal Hemoglobinuria

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.